• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

Prescription Drug Benefit Primer

by Pamela Kumar, RN • April 1, 2006

  • Tweet
  • Email
Print-Friendly Version

This January, the Medicare Prescription Drug Benefit, created by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA), took effect. But does this new program provide an improvement over the network of Medicaid, Medigap, private plans, and out-of-pocket spending that preceded it? American Association of Retired Persons CEO Bill Novelli said, Millions of Americans who have never had drug coverage can now save more money through Medicare Part D rather than turning to Canada to get their prescriptions.1 While the program has had some initial problems, a more complete picture of the actual benefits of this new benefit will emerge in the coming months, as the glitches are corrected and the initial enrollment period ends.

You Might Also Like

  • When It Comes to Drug Development, What Do Our Dollars Buy?
  • A Look at National Health Spending
  • New Medicaid Changes in West Virginia and Kentucky May Affect Otolaryngology Practice
  • Drug Marketing: Different Impacts on Different Physicians
Explore This Issue
April 2006
Figure. It is likely that patients will turn to their physicians when deciding whether they should sign up for Medicare Part D.

click for large version
Figure. It is likely that patients will turn to their physicians when deciding whether they should sign up for Medicare Part D.

Background of the MMA

In December 2003, Congress passed the MMA, and Title 1 of the bill established a new Part D of Medicare, providing seniors and individuals with disabilities the first comprehensive prescription drug benefit ever offered under the Medicare program. After signing the bill, President Bush said, With this law, we’re giving older Americans better choices and more control over their health care, so they can receive the modern medical care they deserve. According to CMS, this represents the most significant improvement of senior health care in nearly 40 years.2

Specifics on How Part D Works

Open enrollment for Medicare beneficiaries began November 15, 2005, and will continue through May 15, with coverage beginning a month after enrollment. Enrollment will open again in November 2006, but coverage will not begin until January 2007 and patients may pay higher premiums. Patients who enroll when they are first eligible or patients who have current prescription drug coverage that is, on average, as good as or better than Medicare coverage will get a penalty-free premium if they decide to join a Medicare Prescription Drug Plan at a later date.

Patients have many options for Part D coverage. Individuals may keep Medicare Part A and B while choosing a separate Prescription Drug Plan (PDP) or they can choose a Medicare Advantage Plan which includes a prescription drug benefit (MA-MDP). If the Medicare Advantage Plan does not offer a prescription drug benefit, they may choose a separate PDP. Beneficiaries pay a monthly premium of approximately $32 per month for prescription drug coverage, with the actual amount of the premium varying by plan (private organizations have contracting with Centers for Medicare and Medicaid Services (CMS) to offer the prescription drug plans).

Pages: 1 2 3 4 | Single Page

Filed Under: Departments, Health Policy, Medical Education, Practice Management Tagged With: healthcare reform, insurance, Medicare, medication, pharmaceuticals, policy, reimbursementIssue: April 2006

You Might Also Like:

  • When It Comes to Drug Development, What Do Our Dollars Buy?
  • A Look at National Health Spending
  • New Medicaid Changes in West Virginia and Kentucky May Affect Otolaryngology Practice
  • Drug Marketing: Different Impacts on Different Physicians

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Have you invented or patented something that betters the field of otolaryngology?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • New Standardized Otolaryngology Curriculum Launching July 1 Should Be Valuable Resource For Physicians Around The World
  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • The Road Less Traveled—at Least by Otolaryngologists

    • The Best Site for Pediatric TT Placement: OR or Office?

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Complications for When Physicians Change a Maiden Name

    • Leaky Pipes—Time to Focus on Our Foundations
    • You Are Among Friends: The Value Of Being In A Group
    • How To: Full Endoscopic Procedures of Total Parotidectomy
    • How To: Does Intralesional Steroid Injection Effectively Mitigate Vocal Fold Scarring in a Rabbit Model?
    • What Is the Optimal Anticoagulation in HGNS Surgery in Patients with High-Risk Cardiac Comorbidities?

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939